HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunometric assay of BN 52080, a heptapeptide C-terminal analogue of sorbin.

Abstract
A novel type of enzyme immunometric assay has been developed for a heptapeptide, BN 52080. This compound is a short C-terminal analogue of sorbin and is under clinical evaluation for treatment of chronic diarrhea. In this solid-phase immobilized epitope immunoassay (SPIE-IA), the peptide is first immunologically bound to polyclonal antibodies adsorbed to a solid phase and then, after covalent immobilization with glutaraldehyde, is released from the antibody paratope by NaOH. The peptide linked to the solid phase is further quantified with a tracer consisting of the same antibodies purified by affinity chromatography and coupled to acetylcholinesterase. This assay has a detection limit of 10 pg/ml and is therefore five times more sensitive than competitive enzyme immunoassay using the same antibodies and BN 52080 coupled to acetylcholinesterase as tracer. The assay is specific and allows direct measurement of peptide in human plasma after subcutaneous or intravenous administration of 200 micrograms of BN 52080 to volunteers.
AuthorsE Ezan, T Tarrade, C Cazenave, T Ardouin, R Genet, J Grassi, J M Grognet, P Pradelles
JournalPeptides (Peptides) Vol. 16 Issue 3 Pg. 449-55 ( 1995) ISSN: 0196-9781 [Print] United States
PMID7651898 (Publication Type: Journal Article)
Chemical References
  • BN 52080
  • Oligopeptides
Topics
  • Amino Acid Sequence
  • Chromatography, High Pressure Liquid
  • Cross Reactions
  • Epitope Mapping (methods)
  • Humans
  • Immunoenzyme Techniques
  • Molecular Sequence Data
  • Oligopeptides (analysis)
  • Reproducibility of Results
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: